Gilead (GILD) announced that the FDA has accepted its new drug application submissions for lenacapavir, the company’s twice-yearly injectable HIV-1 capsid inhibitor-for the prevention of HIV as ...
Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its inner core into the host cell's nuclear membrane. The findings ...
C marks the capsid, and IM marks the putative internal membrane. Right, a fully packaged Jyvaskylavirus virion. The isolate from sample 85 had a single morphotype of approximately 200 nm in size, ...
And there are many places that will stretch their dough into the shape of your love. Bella Napoli in Schaumburg is serving up a 12-inch heart-shaped, woodfired pizza all month, as well as dinner ...
Recently reported HIV-1 capsid (CA) inhibitors GS-CA1 and GS-6207 (an analog of GS-CA1) are first-in-class compounds with long-acting potential. Reportedly, both compounds have greater potency than ...
Virus-like particles (VLPs) are used in different marketed vaccines and are able to induce potent antibody responses. The innate pattern recognition receptors TLR7/8 recognize single stranded (ss) RNA ...
It maintained its integrity through multiple washes, and we noticed no changes in its fit or shape (although we did notice slight pilling on one occasion). That said, this bodysuit fits pretty ...
The successful assembly of a closed protein shell (or capsid) is a key step in the replication of viruses and in the production of artificial viral cages for bio/nanotechnological applications. During ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback